{"transactions":[{"id":699410,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-03T13:50:25.000Z","date":"2026-07-31","kind":"exercise","planned":false,"acquired":false,"shares":11694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":116944,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11694},"source":{"system":"sec-edgar","filing":"0001193125-26-329720","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329720/ownership.xml","form_type":"4"}},{"id":699409,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-03T13:50:25.000Z","date":"2026-07-30","kind":"exercise","planned":false,"acquired":false,"shares":13535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 216,562 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 216,562 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."}],"balance_after":189492,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13535},"source":{"system":"sec-edgar","filing":"0001193125-26-329720","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329720/ownership.xml","form_type":"4"}},{"id":699408,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T13:50:25.000Z","date":"2026-07-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":3326,"price":0.5,"value":1663.0,"ownership":{"direct":true},"balance_after":281899,"source":{"system":"sec-edgar","filing":"0001193125-26-329720","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329720/ownership.xml","form_type":"4"}},{"id":699407,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T13:50:25.000Z","date":"2026-07-31","kind":"exercise","planned":false,"acquired":true,"shares":11694,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":285225,"source":{"system":"sec-edgar","filing":"0001193125-26-329720","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329720/ownership.xml","form_type":"4"}},{"id":699406,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T13:50:25.000Z","date":"2026-07-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3850,"price":0.5,"value":1925.0,"ownership":{"direct":true},"balance_after":273531,"source":{"system":"sec-edgar","filing":"0001193125-26-329720","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329720/ownership.xml","form_type":"4"}},{"id":699405,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-03T13:50:25.000Z","date":"2026-07-30","kind":"exercise","planned":false,"acquired":true,"shares":13535,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":277381,"source":{"system":"sec-edgar","filing":"0001193125-26-329720","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329720/ownership.xml","form_type":"4"}},{"id":706066,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-07-20T19:54:21.000Z","date":"2026-07-19","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":23246,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0001193125-26-308887","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526308887/ownership.xml","form_type":"4"}},{"id":706065,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-20T19:54:21.000Z","date":"2026-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1101,"price":0.47,"value":517.47,"ownership":{"direct":true},"balance_after":263846,"source":{"system":"sec-edgar","filing":"0001193125-26-308887","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526308887/ownership.xml","form_type":"4"}},{"id":706064,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-20T19:54:21.000Z","date":"2026-07-19","kind":"exercise","planned":false,"acquired":true,"shares":3874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":264947,"source":{"system":"sec-edgar","filing":"0001193125-26-308887","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526308887/ownership.xml","form_type":"4"}},{"id":735230,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-17T14:52:21.000Z","date":"2026-06-16","kind":"exercise","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":12500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001193125-26-273552","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526273552/ownership.xml","form_type":"4"}},{"id":735229,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-17T14:52:21.000Z","date":"2026-06-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":3555,"price":0.38,"value":1350.9,"ownership":{"direct":true},"balance_after":261073,"source":{"system":"sec-edgar","filing":"0001193125-26-273552","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526273552/ownership.xml","form_type":"4"}},{"id":735228,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-17T14:52:21.000Z","date":"2026-06-16","kind":"exercise","planned":false,"acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":264628,"source":{"system":"sec-edgar","filing":"0001193125-26-273552","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526273552/ownership.xml","form_type":"4"}},{"id":794650,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-04T15:56:07.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":false,"shares":13535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 216,562 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 216,562 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."}],"balance_after":203027,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13535},"source":{"system":"sec-edgar","filing":"0001193125-26-203272","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203272/ownership.xml","form_type":"4"}},{"id":794649,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-04T15:56:07.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":false,"shares":11694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":128638,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11694},"source":{"system":"sec-edgar","filing":"0001193125-26-203272","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203272/ownership.xml","form_type":"4"}},{"id":794648,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-04T15:56:07.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":13535,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 11,023 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2026."}],"balance_after":252128,"source":{"system":"sec-edgar","filing":"0001193125-26-203272","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203272/ownership.xml","form_type":"4"}},{"id":794647,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-04T15:56:07.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":11694,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":227570,"source":{"system":"sec-edgar","filing":"0001193125-26-203272","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203272/ownership.xml","form_type":"4"}},{"id":803999,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-21T13:13:37.000Z","date":"2026-04-19","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":27120,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0001193125-26-165304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526165304/ownership.xml","form_type":"4"}},{"id":803998,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-21T13:13:37.000Z","date":"2026-04-19","kind":"exercise","planned":false,"acquired":true,"shares":3874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 16,646 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2025."}],"balance_after":215876,"source":{"system":"sec-edgar","filing":"0001193125-26-165304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526165304/ownership.xml","form_type":"4"}},{"id":923412,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-03T15:00:10.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":216561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Performance stock units (\"PSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 30, 2026, the Reporting Person was granted 216,561 PSUs which vest upon the following time-based vesting schedule: the PSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant, subject to satisfaction of the milestone-based vesting condition: the applicable percentage of the PSUs vesting based on a net product sales revenue target for the fiscal year ending December 31, 2026 as reported in the Issuer's Form 10-K. The full amount of the PSUs granted to the Reporting Person is reflected herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 30, 2026, the Reporting Person was granted 216,561 PSUs which vest upon the following time-based vesting schedule: the PSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant, subject to satisfaction of the milestone-based vesting condition: the applicable percentage of the PSUs vesting based on a net product sales revenue target for the fiscal year ending December 31, 2026 as reported in the Issuer's Form 10-K. The full amount of the PSUs granted to the Reporting Person is reflected herein."}],"balance_after":216561,"derivative":{"underlying":"Common Stock","underlying_shares":216561},"source":{"system":"sec-edgar","filing":"0001193125-26-034630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034630/ownership.xml","form_type":"4"}},{"id":923411,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T15:00:10.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":216562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 216,562 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 216,562 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein."}],"balance_after":216562,"derivative":{"underlying":"Common Stock","underlying_shares":216562},"source":{"system":"sec-edgar","filing":"0001193125-26-034630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034630/ownership.xml","form_type":"4"}},{"id":923402,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T13:30:09.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":11695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":140332,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11695},"source":{"system":"sec-edgar","filing":"0001193125-26-034492","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034492/ownership.xml","form_type":"4"}},{"id":923401,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-03T13:30:09.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":11695,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":195356,"source":{"system":"sec-edgar","filing":"0001193125-26-034492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034492/ownership.xml","form_type":"4"}},{"id":936481,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-20T19:49:32.000Z","date":"2026-01-19","kind":"exercise","planned":false,"acquired":false,"shares":3875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":30994,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3875},"source":{"system":"sec-edgar","filing":"0001193125-26-016423","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526016423/ownership.xml","form_type":"4"}},{"id":936480,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-20T19:49:32.000Z","date":"2026-01-19","kind":"exercise","planned":false,"acquired":true,"shares":3875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":183661,"source":{"system":"sec-edgar","filing":"0001193125-26-016423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526016423/ownership.xml","form_type":"4"}},{"id":1008960,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-11-04T17:33:44.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":false,"shares":11694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":152027,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11694},"source":{"system":"sec-edgar","filing":"0001193125-25-264039","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525264039/ownership.xml","form_type":"4"}},{"id":1008959,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-04T17:33:44.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":true,"shares":11694,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":179786,"source":{"system":"sec-edgar","filing":"0001193125-25-264039","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525264039/ownership.xml","form_type":"4"}},{"id":1015580,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-21T15:42:43.000Z","date":"2025-10-19","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":34869,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0001193125-25-244560","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525244560/ownership.xml","form_type":"4"}},{"id":1015579,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-21T15:42:43.000Z","date":"2025-10-19","kind":"exercise","planned":false,"acquired":true,"shares":3874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":168092,"source":{"system":"sec-edgar","filing":"0001193125-25-244560","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525244560/ownership.xml","form_type":"4"}},{"id":1077024,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-08-04T21:27:04.000Z","date":"2025-07-31","kind":"exercise","planned":false,"acquired":false,"shares":11695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The number of restricted stock units disclosed on the Reporting Person's Form 4 filed on April 22, 2025, May 2, 2025 and June 17 , 2025 (\"Affected Form 4 Filings\") were erroneously disclosed as an acquisition in Column 5(A) when it should have been disclosed as a disposition in Column 5(D). All other information in the Affected Form 4 Filings is correct."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":163721,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11695},"source":{"system":"sec-edgar","filing":"0000950170-25-102158","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025102158/ownership.xml","form_type":"4"}},{"id":1077023,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-04T21:27:04.000Z","date":"2025-07-31","kind":"exercise","planned":false,"acquired":true,"shares":11695,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":164218,"source":{"system":"sec-edgar","filing":"0000950170-25-102158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025102158/ownership.xml","form_type":"4"}},{"id":1083661,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-07-22T16:23:02.000Z","date":"2025-07-19","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":38743,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0000950170-25-097498","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025097498/ownership.xml","form_type":"4"}},{"id":1083660,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-22T16:23:02.000Z","date":"2025-07-19","kind":"exercise","planned":false,"acquired":true,"shares":3874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":152523,"source":{"system":"sec-edgar","filing":"0000950170-25-097498","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025097498/ownership.xml","form_type":"4"}},{"id":1101734,"issuer":{"id":6184,"kind":"organization","name":"TerrAscend Corp."},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-25T20:55:19.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":433653,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a restricted share unit (\"RSU\") award for service as a director of the Issuer. The shares underlying the RSUs will vest in full on December 31, 2025, subject to the Reporting Person's continuous service with the Issuer as of the vesting date."}],"balance_after":657930,"source":{"system":"sec-edgar","filing":"0001415889-25-018193","document":"form4-06252025_080616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778129/000141588925018193/form4-06252025_080616.xml","form_type":"4"}},{"id":1108950,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-06-17T21:53:12.000Z","date":"2025-06-16","kind":"exercise","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":25000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-25-087534","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025087534/ownership.xml","form_type":"4"}},{"id":1108949,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-17T21:53:12.000Z","date":"2025-06-16","kind":"exercise","planned":false,"acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":148649,"source":{"system":"sec-edgar","filing":"0000950170-25-087534","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025087534/ownership.xml","form_type":"4"}},{"id":1161886,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-05-03T00:32:09.000Z","date":"2025-04-30","kind":"exercise","planned":false,"acquired":true,"shares":11694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":175416,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11694},"source":{"system":"sec-edgar","filing":"0000950170-25-063063","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025063063/ownership.xml","form_type":"4"}},{"id":1161885,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-03T00:32:09.000Z","date":"2025-04-30","kind":"exercise","planned":false,"acquired":true,"shares":11694,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":136149,"source":{"system":"sec-edgar","filing":"0000950170-25-063063","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025063063/ownership.xml","form_type":"4"}},{"id":1168003,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-04-22T13:57:53.000Z","date":"2025-04-19","kind":"exercise","planned":false,"acquired":true,"shares":3875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":42617,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3875},"source":{"system":"sec-edgar","filing":"0000950170-25-056492","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025056492/ownership.xml","form_type":"4"}},{"id":1168002,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-22T13:57:53.000Z","date":"2025-04-19","kind":"exercise","planned":false,"acquired":true,"shares":3875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":124455,"source":{"system":"sec-edgar","filing":"0000950170-25-056492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025056492/ownership.xml","form_type":"4"}},{"id":1286294,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T17:44:10.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":187110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":187110,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":187110},"source":{"system":"sec-edgar","filing":"0000950170-25-013044","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025013044/ownership.xml","form_type":"4"}},{"id":1286293,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-04T17:44:10.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":374220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (January 31, 2025)."}],"balance_after":374220,"derivative":{"exercise_price":1.7,"expiration_date":"2035-01-31","underlying":"Common Stock","underlying_shares":374220},"source":{"system":"sec-edgar","filing":"0000950170-25-013044","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025013044/ownership.xml","form_type":"4"}},{"id":1298292,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-01-22T14:32:01.000Z","date":"2025-01-19","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":46492,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0000950170-25-007557","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025007557/ownership.xml","form_type":"4"}},{"id":1298291,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-22T14:32:01.000Z","date":"2025-01-19","kind":"exercise","planned":false,"acquired":true,"shares":3874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 8,705 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on October 31, 2024."}],"balance_after":120580,"source":{"system":"sec-edgar","filing":"0000950170-25-007557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025007557/ownership.xml","form_type":"4"}},{"id":1314999,"issuer":{"id":6184,"kind":"organization","name":"TerrAscend Corp."},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-01-03T21:04:46.000Z","date":"2024-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":71704,"price":0.65,"value":46607.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted share units pursuant to an equity plan administered by the Issuer."}],"balance_after":224277,"source":{"system":"sec-edgar","filing":"0001415889-25-000381","document":"form4-01032025_090143.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778129/000141588925000381/form4-01032025_090143.xml","form_type":"4"}},{"id":1383786,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-10-21T19:55:37.000Z","date":"2024-10-19","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":50366,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0000950170-24-115927","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024115927/ownership.xml","form_type":"4"}},{"id":1383785,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-10-21T19:55:37.000Z","date":"2024-10-19","kind":"exercise","planned":false,"acquired":true,"shares":3874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":108001,"source":{"system":"sec-edgar","filing":"0000950170-24-115927","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024115927/ownership.xml","form_type":"4"}},{"id":1450769,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-07-22T13:32:57.000Z","date":"2024-07-19","kind":"exercise","planned":false,"acquired":false,"shares":3875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":54240,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3875},"source":{"system":"sec-edgar","filing":"0000950170-24-085089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024085089/ownership.xml","form_type":"4"}},{"id":1450768,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-22T13:32:57.000Z","date":"2024-07-19","kind":"exercise","planned":false,"acquired":true,"shares":3875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":104127,"source":{"system":"sec-edgar","filing":"0000950170-24-085089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024085089/ownership.xml","form_type":"4"}},{"id":1473261,"issuer":{"id":6184,"kind":"organization","name":"TerrAscend Corp."},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-06-20T21:30:13.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":163334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a restricted share unit (\"RSU\") award for service as a director of the Issuer. The shares underlying the RSUs will vest in full on December 31, 2024, subject to the Reporting Person's continuous service with the Issuer as of the vesting date."}],"balance_after":295981,"source":{"system":"sec-edgar","filing":"0001415889-24-017689","document":"form4-06202024_050608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778129/000141588924017689/form4-06202024_050608.xml","form_type":"4"}},{"id":1478069,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-06-17T18:21:42.000Z","date":"2024-06-16","kind":"exercise","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":37500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-24-074168","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024074168/ownership.xml","form_type":"4"}},{"id":1478068,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-17T18:21:42.000Z","date":"2024-06-16","kind":"exercise","planned":false,"acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":100252,"source":{"system":"sec-edgar","filing":"0000950170-24-074168","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024074168/ownership.xml","form_type":"4"}},{"id":1538666,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-04-19T21:48:06.000Z","date":"2024-04-19","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":58115,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0000950170-24-046134","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024046134/ownership.xml","form_type":"4"}},{"id":1538665,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-19T21:48:06.000Z","date":"2024-04-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1122,"price":2.64,"value":2962.08,"ownership":{"direct":true},"balance_after":87752,"source":{"system":"sec-edgar","filing":"0000950170-24-046134","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024046134/ownership.xml","form_type":"4"}},{"id":1538664,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-19T21:48:06.000Z","date":"2024-04-19","kind":"exercise","planned":false,"acquired":true,"shares":3874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":88874,"source":{"system":"sec-edgar","filing":"0000950170-24-046134","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024046134/ownership.xml","form_type":"4"}},{"id":1675828,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-01-20T02:00:27.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":61989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":61989,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":61989},"source":{"system":"sec-edgar","filing":"0001209191-24-001975","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919124001975/doc4.xml","form_type":"4"}},{"id":1675827,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-01-20T02:00:27.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":371935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (01/19/2024)."}],"balance_after":371935,"derivative":{"exercise_price":2.09,"expiration_date":"2034-01-19","underlying":"Common Stock","underlying_shares":371935},"source":{"system":"sec-edgar","filing":"0001209191-24-001975","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919124001975/doc4.xml","form_type":"4"}},{"id":1737955,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-17T17:36:50.000Z","date":"2023-11-16","kind":"purchase","planned":false,"acquired":true,"shares":85000,"price":0.8894,"value":75599.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of purchase prices paid was $0.8708 to $0.9201. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased at each separate price."}],"balance_after":85000,"source":{"system":"sec-edgar","filing":"0001209191-23-055663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123055663/doc4.xml","form_type":"4"}},{"id":1844271,"issuer":{"id":6184,"kind":"organization","name":"TerrAscend Corp."},"owners":[{"id":27347,"kind":"person","name":"Duarte Ira","position":1,"cik":"0001488864","reported_name":"Duarte Ira","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-26T18:44:08.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":132647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent an annual grant of restricted share units (\"RSUs\") for service as a director of the Issuer.  The shares underlying the RSUs will vest in full on December 31, 2023, subject to the Reporting Person's continuous service with the Issuer as of the vesting date."}],"balance_after":132647,"source":{"system":"sec-edgar","filing":"0001209191-23-039628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778129/000120919123039628/doc4.xml","form_type":"4"}}]}